FloBio is pioneering a novel point-of-care diagnostic platform that analyzes flowing blood to rapidly assess blood clotting function to personalize management.
Addressing The Need For Timely and Cost Effective Decisions
In emergency settings, rapid diagnosis of the underlying blood clotting defects can make the difference between life and death. There is a critical piece missing when timely and actionable information is needed to assess bleeding and thrombotic risk. Current coagulation tests take too long and fail to provide the complete picture to be effectively used in emergency critical care settings. With more than 130M Emergency Department visits annually in the US, this blind spot presents a challenge in identifying and managing patients who present with impaired hemostasis and at risk of bleeding and thrombotic risk.
FloBio is a spin-out of the University of Pennsylvania founded in 2017 and is based at the Pennovation Center in Philadelphia, Pennsylvania. The company also operates out of the PA Biotech Center in Bucks County, Pennsylvania.
Our technology brings the power of microfluidics to the bedside to uncover clotting abnormalities in real-time.
We Look Forward to Hearing From You!
FloBio LLC • 3401 Grays Ferry Avenue, Building 450, Philadelphia, PA 19146 • email@example.com